title: Response to: Sivanandan et al. Prostate Hypofractionated Radiotherapy Trial Results Need to be Interpreted with Caution due to Undertreatment of the Control Arm in the CHHiP Trial.
authors.affiliation: The Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
authors.forename: D
authors.initials: D
authors.lastname: Dearnaley
authors.affiliation: Clatterbridge Cancer Centre, Wirral, UK.
authors.forename: I
authors.initials: I
authors.lastname: Syndikus
authors.affiliation: The Institute of Cancer Research, London, UK.
authors.forename: E
authors.initials: E
authors.lastname: Hall
authors.affiliation: The Institute of Cancer Research, London, UK.
authors.forename: S
authors.initials: S
authors.lastname: Gulliford
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D011467:Prostate; D011471:Prostatic Neoplasms; D000069473:Radiation Dose Hypofractionation; D050397:Radiotherapy, Intensity-Modulated